Keith Michael Gottesdiener, CEO and President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 16,500 shares at $30.08 ($496K) on 2018-11-02, disclosed to the SEC on 2018-11-06.
Open-market sale of $496k RYTM by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |